EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbial metabolites in tumor metabolic reprogramming and immunotherapy: new insights

Yi Wang, Dan Huang, Rongrong Wang, Jiaojiao Yin, Jianying Pei, Chong Zhang

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1706040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Yi Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Gansu University of Chinese Medicine, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Gastrointestinal Microbiome, Bacteria. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Gansu Province, Health Commission of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota and intratumoral microbiota have been recognized as critical regulators of tumor initiation and progression, with their metabolites exerting multifaceted effects on cancer development. This review systematically summarizes the roles and mechanistic classifications of microbial metabolites in tumor metabolic reprogramming, highlighting three principal regulatory layers: direct modulation of metabolic enzyme activity, regulation via signaling pathways, and immunometabolic modulation. Furthermore, it discusses the potential of microbial metabolites in regulating immune cell metabolism and enhancing immunotherapeutic efficacy, alongside summarizing the progress of relevant clinical studies. Finally, the review emphasizes that despite significant advances, current research still faces multiple challenges. Future investigations integrating cutting-edge technologies are essential to accelerate the translation of fundamental findings into clinical applications and to promote the development of metabolite-centered precision therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapyGastrointestinal MicrobiomeBacteriaHumansAnimalsSignal TransductionTumor MicroenvironmentMetabolic Reprogramming

Stichwörter der Autor:innen

cancer immunotherapyclinical translationgut microbiotaimmune cell reprogrammingmicrobial metabolitestumor metabolic reprogramming

Autor:innen und Institutionen

  • School of Public Health, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.
  • Department of Clinical Laboratory center, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou, Gansu, China.

Förderung

  • Natural Science Foundation of Gansu Province
  • Health Commission of Gansu Province

Zitieren

APA

Wang, Y., Huang, D., Wang, R., Yin, J., Pei, J., & Zhang, C. (2025). Microbial metabolites in tumor metabolic reprogramming and immunotherapy: new insights. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1706040

Vancouver

Wang Y, Huang D, Wang R, Yin J, Pei J, Zhang C. Microbial metabolites in tumor metabolic reprogramming and immunotherapy: new insights. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1706040

BibTeX
@article{Wang2025,
  author = {Wang, Yi and Huang, Dan and Wang, Rongrong and Yin, Jiaojiao and Pei, Jianying and Zhang, Chong},
  title = {Microbial metabolites in tumor metabolic reprogramming and immunotherapy: new insights},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1706040}
}
Kostenlos starten →